CHECKMATE PHARMACEUTICALS, INC.

Profile

Company Names

CHECKMATE PHARMACEUTICALS, INC.

Addresses

245 MAIN STREET, 2ND FLOOR, CAMBRIDGE, MA 02142

101 MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA 02142

101 MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA 02142

1 BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

617-682-3625
978-503-2124

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$185,083,274.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2020-06-09 
$85,083,280.00 
$100,083,274.00 
$14,999,994.00 
Equity 
5
2020-04-21 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
4
2019-08-14 
$15,999,999.00 
$15,999,999.00 
$0.00 
Equity 
3
2018-11-28 
$21,999,995.00 
$21,999,995.00 
$0.00 
Equity 
2
2017-06-02 
$27,000,000.00 
$27,000,000.00 
$0.00 
Equity 
1
2015-08-11 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHARLES 
 
ABDALIAN 
EXECUTIVE OFFICER
CHECKMATE PHARMACEUTICALS, INC.
CHUCK 
 
ABDALIAN 
EXECUTIVE OFFICER
CHECKMATE PHARMACEUTICALS, INC.
BEN 
 
AUSPITZ 
DIRECTOR
LIGOCYTE PHARMACEUTICALS INC   |  ULTRAGENYX PHARMACEUTICAL INC.   |  SYMBIOMIX THERAPEUTICS, LLC   |  UNUM THERAPEUTICS, INC.   |  PRECISION BIOSCIENCES INC   |  COMPASS THERAPEUTICS LLC   |  CHECKMATE PHARMACEUTICALS, INC.   |  INDALO THERAPEUTICS, INC.   |  MEVES PHARMACEUTICALS, INC.   |  ZERO POINT FIVE THERAPEUTICS, INC.   |  ANTLIA BIOSCIENCE, INC.
KAREN 
 
BRENNAN 
EXECUTIVE OFFICER
CHECKMATE PHARMACEUTICALS, INC.
KLEEM 
 
CHAUDHARY 
EXECUTIVE OFFICER
CHECKMATE PHARMACEUTICALS, INC.   |  HYKU BIOSCIENCES INC.
PETER 
 
COLABUONO 
DIRECTOR
CHECKMATE PHARMACEUTICALS, INC.   |  SOLVE THERAPEUTICS, INC.   |  SUNNYBAY BIOTECH, INC.   |  FIREFLY BIO, INC.
KEITH 
 
FLAHERTY 
DIRECTOR
CLOVIS ONCOLOGY, INC.   |  LOXO ONCOLOGY, INC.   |  STRATA ONCOLOGY, INC.   |  CHECKMATE PHARMACEUTICALS, INC.   |  KINNATE BIOPHARMA INC.   |  SCORPION THERAPEUTICS, INC.   |  ANTARES THERAPEUTICS, INC.
ALAN 
 
FUHRMAN 
DIRECTOR
NAVISCAN PET SYSTEMS INC   |  NAVISCAN, INC   |  HEALIONICS CORP   |  AMBIT BIOSCIENCES CORP   |  CHECKMATE PHARMACEUTICALS, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  TYRA BIOSCIENCES, INC.
COREY 
 
GOODMAN 
DIRECTOR
LIMERICK BIOPHARMA INC   |  IPIERIAN, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SECOND GENOME, INC.   |  MIRNA THERAPEUTICS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  ALEXO THERAPEUTICS LTD   |  CHECKMATE PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  NFLECTION THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  TALLAC THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  ATTRALUS, INC.   |  INSAMO INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
ART 
 
KRIEG 
EXECUTIVE OFFICER, DIRECTOR
CHECKMATE PHARMACEUTICALS, INC.
ARTHUR 
 
KRIEG 
EXECUTIVE OFFICER, DIRECTOR
CHECKMATE PHARMACEUTICALS, INC.
ARTHUR 
A. 
KRIEG 
EXECUTIVE OFFICER, DIRECTOR
CHECKMATE PHARMACEUTICALS, INC.
ARTHUR 
M. 
KRIEG 
EXECUTIVE OFFICER, DIRECTOR
RANA THERAPEUTICS, INC.   |  CHECKMATE PHARMACEUTICALS, INC.
BARRY 
 
LABINGER 
EXECUTIVE OFFICER, DIRECTOR
CHECKMATE PHARMACEUTICALS, INC.
JON 
 
LIEBER 
EXECUTIVE OFFICER
XCELLEREX, INC.   |  CHECKMATE PHARMACEUTICALS, INC.
JONATHAN 
 
LIEBER 
EXECUTIVE OFFICER
BUCKLAND PARTNERS LP   |  BUCKLAND PARTNERS FOCUS FUND LP   |  BUCKLAND PARTNERS GROWTH FUND LP   |  BUCKLAND PARTNERS, L.P.   |  LEDBURY INC.   |  HISTOGENICS CORP   |  CHECKMATE PHARMACEUTICALS, INC.   |  SALARIUS PHARMACEUTICALS, INC.
DAVID 
 
MAURO 
EXECUTIVE OFFICER
CHECKMATE PHARMACEUTICALS, INC.   |  PRELUDE THERAPEUTICS INC
MICHAEL 
 
POWELL 
DIRECTOR
ALVINE PHARMACEUTICALS INC   |  TRIUS THERAPEUTICS INC   |  ASCENTA THERAPEUTICS, INC.   |  ARCHIPELAGO LEARNING, INC.   |  OBJECTVIDEO INC   |  EXCELLENT ENERGY SOLUTIONS, LLC   |  SOFINNOVA VENTURE PARTNERS VIII, L.P.   |  MIRNA THERAPEUTICS, INC.   |  SUPPLY VISION, INC.   |  PASSPORT SYSTEMS INC   |  CATALYST BIOSCIENCES INC   |  CHIGWELL LTD   |  MERCURY MEDIA SCIENCE B LTD   |  CHECKMATE PHARMACEUTICALS, INC.   |  DAUNTLESS 1, INC.   |  DAUNTLESS 2, INC.   |  E-CIRCUIT MOTORS, INC.   |  PIONYR IMMUNOTHERAPEUTICS, INC.   |  TM TECHNOLOGIES INC   |  GALERA THERAPEUTICS, INC.   |  SYNLOGIC, INC.   |  AEOVIAN PHARMACEUTICALS, INC.
RAMANI 
 
VARANASI 
EXECUTIVE OFFICER
CHECKMATE PHARMACEUTICALS, INC.   |  X-BIOTIX THERAPEUTICS, INC.
ROBERT 
 
WEISSKOFF 
DIRECTOR
TETRAPHASE PHARMACEUTICALS INC   |  ACCURI CYTOMETERS INC   |  TRANSAVE INC   |  IKANO THERAPEUTICS INC.   |  ACORN CARDIOVASCULAR INC   |  VIEWRAY INC   |  BIOCONNECT SYSTEMS INC   |  AMPHORA MEDICAL, INC.   |  CARIBOU BIOSCIENCES, INC.   |  IOWA APPROACH, INC.   |  ZENFLOW, INC.   |  TEMPEST THERAPEUTICS, INC.   |  FARAPULSE, INC.   |  CHECKMATE PHARMACEUTICALS, INC.   |  AFFINIA THERAPEUTICS INC.   |  XILIO THERAPEUTICS, INC.   |  RARECYTE, INC.   |  SHOUTI INC.   |  BASECAMP BIO INC.   |  ADELA, INC.
JAMES 
 
WOOLDRIDGE 
EXECUTIVE OFFICER
CHECKMATE PHARMACEUTICALS, INC.
CHARLES 
 
YON 
EXECUTIVE OFFICER
CHECKMATE PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-06-18
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-06-09 
2020-04-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-04-21 
2020-01-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-14 
2019-08-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-14 
2019-04-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-28 
2018-12-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-28 
2017-06-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-02 
2017-02-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-11 
2016-06-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-11 
2015-08-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#